Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-30

FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OVIDREL (choriogonadotropin alfa) submitted by EMD Serono, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ovidrel (Choriogonadotropin alfa)

Snippet

SUPPL AP for OVIDREL (CHORIOGONADOTROPIN ALFA)